Citation 120188

MIZOGUCHI,Y: KOMATS,Y: OHKURA,Y:. (1992). EFFECTS OF SHO-SAIKO-TO ON CYTOKINE CASCADE AND ARACHIDONIC ACID CASCADE.. 319()

Citation Details

Title	EFFECTS OF SHO-SAIKO-TO ON CYTOKINE CASCADE AND ARACHIDONIC ACID CASCADE.
Authors	MIZOGUCHI,Y: KOMATS,Y: OHKURA,Y:
Year	1992
Volume	319
Issue

Summary

Year: 1992

Journal: Unknown

Organisms and Their Experiments (7)

Bupleurum falcatum (APIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LEUKOTRIENE B-4 INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	PHOSPHOLIPASE A2 INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	ARACHIDONIC ACID RELEASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	ANTIBODY FORMATION ENHANCEMENT	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	INTERLEUKIN-6 FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	INTERLEUKIN-III INDUCTION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
7	INTERLEUKIN-II FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
8	INTERLEUKIN-1 FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
9	ALANINE AMINOTRANSFERASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE
10	ASPARTATE TRANSAMINASE LEVEL DECREASE	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE
11	HEPATITIS ANTIGEN EXPRESSION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE

Pinellia ternata (ARACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LEUKOTRIENE B-4 INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	PHOSPHOLIPASE A2 INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	ARACHIDONIC ACID RELEASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	ANTIBODY FORMATION ENHANCEMENT	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	INTERLEUKIN-6 FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	INTERLEUKIN-III INDUCTION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
7	INTERLEUKIN-II FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
8	ALANINE AMINOTRANSFERASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE
9	ASPARTATE TRANSAMINASE LEVEL DECREASE	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE
10	HEPATITIS ANTIGEN EXPRESSION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE

Scutellaria baicalensis (LAMIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LEUKOTRIENE B-4 INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	PHOSPHOLIPASE A2 INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	ARACHIDONIC ACID RELEASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	ANTIBODY FORMATION ENHANCEMENT	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	INTERLEUKIN-6 FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	INTERLEUKIN-II FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
7	INTERLEUKIN-1 FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
8	ALANINE AMINOTRANSFERASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE
9	ASPARTATE TRANSAMINASE LEVEL DECREASE	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE
10	HEPATITIS ANTIGEN EXPRESSION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE

Ziziphus jujuba (RHAMNACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LEUKOTRIENE B-4 INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	PHOSPHOLIPASE A2 INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	ARACHIDONIC ACID RELEASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	ANTIBODY FORMATION ENHANCEMENT	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	INTERLEUKIN-6 FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	INTERLEUKIN-III INDUCTION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
7	INTERLEUKIN-II FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
8	INTERLEUKIN-1 FORMATION STIMULATION	CHEMICAL IONIZATION MASS SPECTRUM REPORTEDPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
9	ALANINE AMINOTRANSFERASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE
10	ASPARTATE TRANSAMINASE LEVEL DECREASE	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE
11	HEPATITIS ANTIGEN EXPRESSION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE

Panax ginseng (ARALIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LEUKOTRIENE B-4 INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	PHOSPHOLIPASE A2 INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	ARACHIDONIC ACID RELEASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	ANTIBODY FORMATION ENHANCEMENT	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	INTERLEUKIN-6 FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	INTERLEUKIN-III INDUCTION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
7	INTERLEUKIN-II FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
8	INTERLEUKIN-1 FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
9	ALANINE AMINOTRANSFERASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE
10	ASPARTATE TRANSAMINASE LEVEL DECREASE	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE
11	HEPATITIS ANTIGEN EXPRESSION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE

Glycyrrhiza glabra (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LEUKOTRIENE B-4 INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	PHOSPHOLIPASE A2 INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	ARACHIDONIC ACID RELEASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	ANTIBODY FORMATION ENHANCEMENT	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	INTERLEUKIN-6 FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	INTERLEUKIN-III INDUCTION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
7	INTERLEUKIN-II FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
8	INTERLEUKIN-1 FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
9	ALANINE AMINOTRANSFERASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE
10	ASPARTATE TRANSAMINASE LEVEL DECREASE	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE
11	HEPATITIS ANTIGEN EXPRESSION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE

Zingiber officinale (ZINGIBERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LEUKOTRIENE B-4 INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	PHOSPHOLIPASE A2 INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	ARACHIDONIC ACID RELEASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	ANTIBODY FORMATION ENHANCEMENT	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	INTERLEUKIN-6 FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	INTERLEUKIN-III INDUCTION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
7	INTERLEUKIN-II FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
8	INTERLEUKIN-1 FORMATION STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
9	ALANINE AMINOTRANSFERASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE
10	ASPARTATE TRANSAMINASE LEVEL DECREASE	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE
11	HEPATITIS ANTIGEN EXPRESSION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	None	ACTIVE

Show SPARQL Queries (1)